Legal Marijuana Market Trends and Overview

The legal marijuana market was valued at USD 16.90 billion in 2022 and is projected to experience a compound annual growth rate (CAGR) of 25.2% from 2023 to 2030. It is estimated that the market will reach a staggering USD 102.04 billion by 2030.

The legal marijuana industry has witnessed significant growth in recent years, and this trend is expected to continue in the coming decade. With increasing acceptance and legalization of marijuana for both medical and recreational purposes, the market is poised for substantial expansion.

In 2022, the legal marijuana market reached a valuation of USD 16.90 billion, reflecting the growing demand and changing attitudes towards cannabis. This upward trajectory is anticipated to accelerate, with a projected CAGR of 25.2% from 2023 to 2030. By the end of this period, the market is estimated to soar to an impressive USD 102.04 billion.

The legalization of marijuana has opened up new avenues for businesses and investors, leading to a surge in market opportunities. As more countries and states embrace the potential benefits of cannabis, the legal marijuana market is set to witness unprecedented growth.

Get Free Sample Report @ https://www.snsinsider.com/sample-request/1046

Factors such as the increasing recognition of marijuana's medicinal properties, the growing acceptance of recreational use, and the potential economic benefits are driving the expansion of this market. Additionally, advancements in cultivation techniques, product innovation, and regulatory frameworks are further propelling the industry forward.

In conclusion, the legal marijuana market is experiencing remarkable growth and is expected to continue its upward trajectory. With a projected CAGR of 25.2% from 2023 to 2030, the market is estimated to reach a staggering USD 102.04 billion. As the industry gains more acceptance and legalization, businesses and investors are presented with lucrative opportunities in this rapidly evolving market.

KEY MARKET SEGMENTATION:

By Type

• Medical
• Recreational

By Product

• Buds
• Oils
• Tinctures

By Application

• Chronic Pain    
• Neurological Disorders 
• Cancer
• Others

KEY PLAYERS:

The Major Players are Canopy Growth Corporation, GBSciences Inc, CanniMed Ltd, Cannabis Sativa Inc, GW Pharmaceuticals Plc, Aphria, Pfizer Inc., Emerald Health Therapeutics Inc, Medical Marijuana Inc, MediPharm Labs, and others.

About US:

SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.

We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.

Contact Us:

Akash Anand – Head of Business Development & Strategy,

info@snsinsider.com,

Phone: +1-415-230-0044 (US) | +91-7798602273 (IND),

Website: https://www.snsinsider.com